14.54
price up icon3.41%   0.48
after-market Dopo l'orario di chiusura: 14.54
loading
Precedente Chiudi:
$14.06
Aprire:
$14.15
Volume 24 ore:
68,226
Relative Volume:
0.31
Capitalizzazione di mercato:
$544.39M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-1.76%
1M Prestazione:
+33.39%
6M Prestazione:
+16.60%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$14.09
$14.62
Intervallo di 1 settimana:
Value
$13.43
$15.70
Portata 52W:
Value
$5.485
$31.13

Oruka Therapeutics Inc Stock (ORKA) Company Profile

Name
Nome
Oruka Therapeutics Inc
Name
Telefono
650-606-7910
Name
Indirizzo
855 OAK GROVE AVE., MENLO PARK
Name
Dipendente
28
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
ORKA's Discussions on Twitter

Confronta ORKA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ORKA
Oruka Therapeutics Inc
14.54 526.41M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-22 Iniziato BTIG Research Buy
2025-02-04 Iniziato Wolfe Research Outperform
2024-10-11 Iniziato Stifel Buy
2024-10-07 Iniziato H.C. Wainwright Buy
2024-09-17 Iniziato Leerink Partners Outperform
2024-09-16 Iniziato TD Cowen Buy
2024-09-13 Iniziato Jefferies Buy
2018-02-27 Iniziato Ascendiant Capital Markets Buy
2013-10-09 Iniziato Dawson James Buy
Mostra tutto

Oruka Therapeutics Inc Borsa (ORKA) Ultime notizie

pulisher
03:02 AM

What drives Oruka Therapeutics Inc. stock priceOverwhelming financial success - Autocar Professional

03:02 AM
pulisher
09:40 AM

Is Oruka Therapeutics Inc. a good long term investmentAccelerated investment success - Autocar Professional

09:40 AM
pulisher
08:01 AM

H.C. Wainwright reiterates Buy rating on Oruka Therapeutics stock as FDA clears IND - Investing.com Canada

08:01 AM
pulisher
04:25 AM

Oruka Therapeutics Shares Climb After FDA Greenlights Psoriasis Drug Trial - MSN

04:25 AM
pulisher
03:44 AM

Oruka Therapeutics Inc. Stock Analysis and ForecastMassive profits - Autocar Professional

03:44 AM
pulisher
02:33 AM

What analysts say about Oruka Therapeutics Inc. stockExponential return rates - jammulinksnews.com

02:33 AM
pulisher
02:17 AM

Wedbush Reiterates Outperform Rating for Oruka Therapeutics (NASDAQ:ORKA) - Defense World

02:17 AM
pulisher
Jul 22, 2025

Oruka Therapeutics Announces IND Clearance for EVERLAST-A - GlobeNewswire

Jul 22, 2025
pulisher
Jul 21, 2025

Oruka Therapeutics stock rises after FDA clears IND for psoriasis drug - Investing.com India

Jul 21, 2025
pulisher
Jul 21, 2025

Stifel reiterates Buy rating on Oruka Therapeutics stock with $47 target - Investing.com Canada

Jul 21, 2025
pulisher
Jul 21, 2025

Oruka Therapeutics: Revolutionizing Psoriasis Treatment with Extended-Dosing Biologics - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

FDA clears Oruka’s IND for psoriasis drug ORKA-001 phase 2a trial - Investing.com India

Jul 21, 2025
pulisher
Jul 21, 2025

Oruka Therapeutics Announces IND Clearance for EVERLAST-A Phase 2a Trial of ORKA-001 in Psoriasis with Phase 1 Data to be Presented at EADV in September - Yahoo Finance

Jul 21, 2025
pulisher
Jul 18, 2025

How high can Oruka Therapeutics Inc. stock price go in 2025Balanced Risk Reward Portfolio - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

How Oruka Therapeutics Inc. stock performs during market volatilityDaily Volume Leaders - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Oruka Therapeutics Inc. stock attracts strong analyst attentionFree Real-Time Stock Data - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Oruka Therapeutics Inc. stock price move sharplyWeekly Big Movers - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Rating of “Buy” from Analysts - Defense World

Jul 15, 2025
pulisher
Jul 04, 2025

Oruka Therapeutics announces COO appointment - MSN

Jul 04, 2025
pulisher
Jul 02, 2025

Oruka Therapeutics Shares Soar 16.1% on Executive Promotion, Index Inclusion - AInvest

Jul 02, 2025
pulisher
Jul 01, 2025

Oruka Therapeutics Promotes Laura Sandler to COO - MarketScreener

Jul 01, 2025
pulisher
Jul 01, 2025

Oruka Therapeutics promotes Laura Sandler to chief operating officer - Investing.com

Jul 01, 2025
pulisher
Jul 01, 2025

Oruka Therapeutics Announces Promotion of Laura Sandler to Chief Operating Officer - GlobeNewswire

Jul 01, 2025
pulisher
Jul 01, 2025

Oruka Therapeutics Appoints New Chief Operating Officer - TipRanks

Jul 01, 2025
pulisher
Jun 29, 2025

Oruka Therapeutics, Inc.(NasdaqGM: ORKA) added to Russell 3000E Index - MarketScreener

Jun 29, 2025
pulisher
Jun 20, 2025

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Given Average Recommendation of “Buy” by Analysts - Defense World

Jun 20, 2025
pulisher
Jun 14, 2025

Wall Street Zen Downgrades Oruka Therapeutics (NASDAQ:ORKA) to Sell - Defense World

Jun 14, 2025
pulisher
Jun 08, 2025

Millennium Management LLC Makes New Investment in Oruka Therapeutics, Inc. (NASDAQ:ORKA) - Defense World

Jun 08, 2025

Oruka Therapeutics Inc Azioni (ORKA) Dati Finanziari

Non sono disponibili dati finanziari per Oruka Therapeutics Inc (ORKA). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):